Treating Young Children With Attention Deficit Hyperactivity Disorder
NCT07300956
This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Attention-Deficit/Hyperactivity Disorder (ADHD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 3 to 5 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Last updated on ClinicalTrials.gov
- September 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Stanford Medicine Children's Health · Palo Alto, CA
Massachusetts · 1
- Boston Children's Hospital · Boston, MA
Missouri · 1
- Children's Mercy Hospital · Kansas City, MO
Ohio · 1
- Cincinnati Children's Hospital Medical Center · Cincinnati, OH
Pennsylvania · 1
- Children's Hospital of Philadelphia · Philadelphia, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.